Trials / Completed
CompletedNCT03311477
A Study to Evaluate the Safety and Pharmacokinetics ABBV-399 in Japanese Participants With Solid Tumors
A Phase I Study to Evaluate the Safety and Pharmacokinetics of ABBV-399 in Japanese Subjects With Advanced Solid Tumors
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 9 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
An open-label, dose-escalation study designed to evaluate the safety, pharmacokinetics, and preliminary efficacy of ABBV-399 in participants with advanced solid tumors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ABBV-399 | Intravenous infusion |
Timeline
- Start date
- 2017-11-06
- Primary completion
- 2019-03-04
- Completion
- 2019-03-04
- First posted
- 2017-10-17
- Last updated
- 2019-03-14
Locations
2 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT03311477. Inclusion in this directory is not an endorsement.